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Adaptor protein-3 (AP-3) is a hetero-tetrameric complex, which regulates vesicular trafficking. 
Mutations of the β3A subunit cause the Hermansky-Pudlak syndrome type 2 (HPS-2), a rare genetic 
disease characterized by albinism, platelet defects and recurrent infections. Likewise, pearl mice, 
which lack functional AP-3, show several HPS-2 defects. AP-3 absence results in defective TLR 
trafficking and signalling in dendritic cells (DC), but its effect on the efficiency of the in vivo 
antiviral response is unclear. We evaluated the impact of AP-3 deficiency on the distribution of DC 
subsets, IFN production, and the susceptibility to murine cytomegalovirus (MCMV) infection. 
Pearl mice showed a distribution and frequency of conventional (cDC) and plasmacytoid DC 
(pDC) similar to that of wt mice both before and after MCMV infection. Moreover, pearl mice 
controlled MCMV infection even at high virus doses and showed a normal production of IFN- 
Since pDC, but not cDC, from pearl mice showed an impaired IFN- and TNF- production in 
response to prototypic DNA (MCMV and HSV) or RNA (VSV) viruses in vitro, it is likely that 
MCMV infection can be controlled in vivo independently of an efficient production of IFN- by 
pDC, and that AP-3 complex has a minimal impact on protective antiviral responses.  
 
 




Adaptor complexes (AP-1 through 5) are hetero-tetrameric proteins involved in distinct intracellular 
vesicular transport pathways. AP-3 escorts proteins from the early trans-Golgi network to 
lysosome-related organelles (Dell’Angelica et al 2009; Feng et al 1999). A mutation in the gene 
ADTB3A, which encodes for the 3A subunit, causes the Hermansky-Pudlak syndrome type 2 
(HPS-2), an autosomal recessive inherited disease characterized by partial albinism, prolonged 
bleeding and immunodeficiency (Badolato et al 2007).  
Interestingly, human HPS-2 has its murine counterpart in the pearl strain of mice, which bear a 
mutation in the AP3B1 gene, the mouse orthologous of ADTB3A, and share many aspects of the 
human disease (Feng et al 1999). 
Being responsible for protein trafficking to lysosomes, AP-3 affects important immune processes. 
In fact, both AP-3-deficient mice and HPS-2 patients show abnormalities involving the polarization 
of lytic granules inside cytotoxic T cells and the intracellular localization of CD1b and CD1d, 
which are required for the presentation of lipid antigens and NKT cell development (Elewaut et al 
2003). AP-3 has been linked to TLR signalling in dendritic cells (DC) and is required for TLR4 
recruitment to phagosome and MHCII presentation of antigens internalized by phagocytosis 
(Mantegazza et al 2012). Furthermore, AP-3, as well as the other HPS proteins, is required for 
plasmacytoid DC (pDC) signalling through TLR7 and TLR9 (Blasius et al 2010; Sasai et al 2010). 
These facts point out the involvement of AP-3 in the development of efficient innate and adaptive 
immune responses. DC play a pivotal role in the response to a wide variety of viruses both in 
humans and mice, including cytomegalovirus (CMV) (Rahman et al 2011, Rölle and Olweus 2009). 
The experimental model of murine CMV (MCMV) infection greatly advanced our understanding of 
the DC role and, due to the many features shared with the species-specific human counterpart virus 
(HCMV), it is widely used to investigate the innate and adaptive immune responses to CMV in vivo 
(Krmpotic et al 2003; Riera et al 2000). In this regard, it has been established that conventional DC 




(cDC) support productive MCMV infection both in vitro and in vivo (Andrews et al 2001), but they 
also have an important role in the control and clearance of viral infection. After infection, CD11b 
DC secrete innate immunity cytokines, including IFN- and are involved in NK cell activation. 
pDC are considered the main producers of IFN-and IFN- in response to MCMV infection in a 
TLR9- and MyD88-dependent manner (Krug et al 2004). However, several studies showed that, in 
addition to pDC, other cell types, such as cDC, macrophages and lymphoid-tissue stromal cells, can 
produce IFN- in response to Herpes Simplex virus (HSV) or CMV infections. Moreover, IFN- 
production by non-pDC is largely TLR9-independent and responsible for most of IFN- produced 
(Hochrein et al 2004; Sozzani et al 2010). Although AP-3 protein is required for TLR9 and TLR7 
activation in pDC, it is unclear whether the pearl mice defect can influence the in vivo immune 
response to viral infections. The purpose of this study was to determine the degree of susceptibility 
of pearl mice to MCMV infection and to assess whether MCMV infection modulates DC subsets 
and IFN production in these mice. 
In order to characterize DC, CD34+ bone marrow (BM) positive cells from pearl mice (kindly 
provided by Prof. Dr. Stephan Ehl) and C57BL/6J wt mice (Charles River Breeding Laboratories) 
were purified by positive immunoselection and cultured with mGM-CSF (40 ng/ml) and Flt-3L 
(100 ng/ml) to generate cDC, or with Flt3L (200ng/ml) only to generate pDC (Del Prete et al 2007). 
As previously shown (Sasai et al 2010), pearl mice DC were comparable to wt DC in terms of 
surface expression of CD11c, CD11b, MHC I and II and CD80 (data not shown). Then, cDC and 
pDC from pearl mice were functionally characterized for cytokine production in response to 
different virus infections. Since TLR7 and TLR9 are required for pDC to sense viral nucleic acids, 
we investigated the response of AP-3-deficient pDC to prototypic DNA viruses, such as MCMV 
(Smith strain, ATCC VR.194) and HSV-2 (a clinical isolate), which stimulate pDC mainly through 
TLR9, and to a RNA virus, such as the Vesicular Stomatitis virus (VSV, serotype Indiana), which 




triggers IFN- production by pDC mainly through TLR7 (Ahmed et al 2009). To this end, pDC 
were infected with the different viruses at a MOI of 1, or treated as a positive control for TLR-9 
stimulation, with CpG 2216 type-A (20 g/ml) for 24 hours. 
As shown in Fig. 1A, regardless of the virus, a severe defect in IFN- production, both at the 
mRNA (left panel) and protein levels (middle panel), was observed in pearl pDC compared to wt 
pDC. A similar defect was observed in TNF- secretion as well (Fig. 1A, right panel). In contrast, 
no significant differences in IFN- levels were observed after MCMV stimulation of pearl cDC 
compared to wt cDC (Fig. 1B, left panel), and cDC from pearl mice were able to produce normal 
amounts of TNF- after either MCMV or LPS stimulation (1 g/ml) (Fig. 1B, right panel). Results 
reported in Fig.1 indicate that the AP-3 deficiency in pearl mice selectively impairs the ability of 
pDC, but not of cDC, to respond to different viruses that signal through TLR7 or TLR9.  
Moreover, these observations suggest that AP-3 deficiency abolishes the TLR9-mediated IFN-
response of pDC during MCMV infection. This, in turn, may lead to an increased susceptibility to 
MCMV in vivo. In this regard, MCMV infection is considered a suitable experimental model to 
study systemic Herpesvirus infection, as well as the TLR-dependent and -independent mechanisms 
of type I IFN induction. In fact, in the host MCMV spreads through the blood reaching liver and 
spleen, which are the principal sites of viral replication, and induces a type I IFN response mediated 
by different cell-type-specific mechanisms of viral recognition and IFN expression (Steinberg et al 
2009). 
Mouse splenic DC include three main populations. The cDC splenic subsets can be identified on the 
basis of the presence or absence of a CD8homodimer, while pDC are characterized by high B220 
expression (Del Prete et al 2004). Both pDC and cDC play an important role in the antiviral 
response to MCMV: in addition, there is evidence that changes in their proportion can account for 
different susceptibility to viral infections (Andrews et al 2003;Traub et al 2012). In order to further 




investigate whether the AP-3 deficiency affects the normal distribution of different splenic DC 
populations, we characterized the DC subsets for specific cell surface markers (Fig. 2A). DC were 
derived from wt and pearl mice spleens under steady-state conditions or after infection with 
MCMV (36 hours following challenge with 3x10
5 
PFU i.p.). As shown in Fig. 2B, the phenotypic 
characterization of spleen-derived DC from pearl and wt mice revealed similar proportions of 
CD11c+ DC (upper left panel), and comparable frequencies of cDC, both CD11b+CD8- (upper 
right panel) and CD11b-CD8+ (lower left panel), and of B220+ Siglec-H+ pDC (lower right 
panel). In addition, pearl mice maintained a stable population of CD11c+ cells following MCMV 
infection and no significant differences were found in the frequency of CD11b+CD8-, CD11b-
CD8+, and B220+Siglec-H+ (Fig. 2B). 
The AP-3 complex is also required for normal trafficking of CD1d, a molecule involved in the 
presentation of lipid antigens to NKT cells and in their selection. CD1d is constitutively expressed 
on CD11c+ cells and is reduced during virus infection (Lin et al 2005). In pearl mice, the abnormal 
trafficking of CD1d leads to increased expression of CD1d on the surface of different cell types and 
to a decreased expression in late endosomes coupled with a decreased NKT cell number (Elewaut et 
al 2003). In agreement with these data, FACS analysis showed a more than two-fold increase in 
CD1d expression levels on the surface of total splenic pearl mice-derived DC compared to wt cells 
(Fig. 2C upper and lower left panels). However, MCMV infection strongly reduced CD1d 
expression in pearl mice to levels comparable to those observed in wt mice (Fig. 2C upper and 
lower right panels). 
To assess the effects of AP-3 deficiency in the cytokine response to in vivo MCMV infection, levels 
of IFN-NF-and IFN-were evaluated by ELISA in the sera of wt and pearl mice 36 hours 
after MCMV challenge (3x10
5 
PFU, i.p.), when cytokine production exhibits a sharp peak (Orange 
et al 1996). According to several reports (Dalod et al 2003; Delale et al 2005; Swiecki et al 2010, 




Zucchini et al 2008a), pDC are essential for the in vivo production of IFN-during the initial stages 
of MCMV infection. However, we did not find any difference in the circulating levels of IFN- in 
pearl compared to wt mice at 36 hours (Fig. 3A upper left panel), despite the defective IFN-
production observed in vitro in pearl mice-derived pDC stimulated with MCMV (Fig. 1A). As 
shown in Fig. 3A (upper right panel), similar levels of IFN-were also detected at a later time point 
(48 hours), a time in which IFN-production is considered non pDC-dependent (Delale et al 2005; 
Swiecki et al 2010). A mild non-significant decrease in TNF- production was observed in pearl 
mice compared to wt (Fig. 3A lower left panel). IFN- levels were evaluated in the sera of MCMV-
infected mice as well as in mice injected with the glycolipid antigen -galactosylceramide (-
GalCer) (100 ng/ml), which induces NKT cell activation in a CD1d-dependent manner (Kawano et 
al 1997). Similarly to IFN-, pearl mice were as efficient as wt animals in IFN-production 
following MCMV infection. In contrast, the IFN- levels were strongly reduced in -GalCer-treated 
pearl mice compared to wt (Fig. 3A lower right panel), in agreement with the occurrence of a 
reduced number of Vα14 invariant NK T (Vα14i NK T) cells, which has previously been shown in 
pearl mice (Elewaut et al 2003). 
To determine the overall susceptibility to MCMV infection, AP-3-deficient mice were challenged 
with different viral doses. The mortality and viral load in different organs were assessed in 




PFU, all wt and AP3-
deficient mice survived (Fig. 3B). At the higher dose, 5x10
5 
PFU, survival of both wt and AP-3-
deficient mice was approximately 80% (Fig. 3B). The viral titres in multiple tissues of pearl and wt 
mice infected with different doses of MCMV (1, 3 or 5 x 10
5
 PFU) were assessed at different post-
infection (p.i.) time points. As shown in Fig. 3C, in the liver of pearl and wt mice similar levels of 
MCMV were titrated at 2 days p.i. Since MCMV replicates in salivary glands during the late stage 
of infection, the viral titres were measured in salivary glands on day 15 p.i., and no differences were 




found. Determination of viral titres in liver, lung and spleen on day 15 p.i., revealed that pearl mice, 
as wt animals, were able to reduce MCMV loads, regardless of the dose, below detection limit. 
Taken together, these observations suggest that pearl mice, despite a major defect affecting the in 
vitro pDC response to TLR7 and TLR9 stimuli, produce normal levels of IFN- following MCMV 
infection and control the infection with the same efficiency as wt animals. 
The role of pDC in the early innate control varies according to the virus and the infection model 
(Cervantes-Barragan et al 2012). Several reports explored the role of pDC and IFN- production in 
response to MCMV infection, by using different models of pDC depletion or functional impairment 
in the absence of the TLR9/MyD88 pathway. For example, pDC depletion in Ikaros
L/L
 mice 
(Allmann et al 2006) or BDCA2-DTR transgenic mice (Swiecki et al 2010) resulted in deficient 
production of IFN- at early time points after MCMV infection. However, IFN- production was 
restored at later time points (Allmann et al 2006; Swiecki et al 2010) by cells other than pDC. The 
effects of pDC depletion on the overall anti-MCMV response seem to be dependent on viral doses. 
In fact, at high viral loads, BDCA2-DTR mice, similarly to what we observed in pearl mice, were 
efficient in containing MCMV replication (Swiecki et al 2010). A less efficient control of viral 
replication in the Ikaros
L/L
 pDC depletion model may be due to the potential impairment of other 
hematopoietic lineages (Allmann et al 2006). 
The role of TLR9 in MCMV infection, in the presence or in the absence of pDC, has been carefully 
characterized by Delale et al (2005). Interestingly, these authors observed that TLR9-/- mice 
maintained a pDC-dependent IFN- production, in response to MCMV infection, notwithstanding 
the in vitro defective IFN- secretion. These findings, in line with our data, suggest that some 
compensatory mechanisms may occur during the in vivo response to MCMV infection. It is 
therefore conceivable that in pearl mice other haematopoietic and non haematopoietic cells, (i.e., 
lymphoid-tissue stromal cells) could contribute to the overall in vivo production of IFN-




(Andoniou et al 2005; Delale et al 2005). In this regard, it has been shown that cDC are able to 
produce type I IFN in a TLR9-independent manner, and that TLR2 and TLR3 may play a role in the 
defence against MCMV infection (Tabeta et al 2004; Barbalat  et al 2009). Moreover, a TLR-
independent production of IFN-by cDC in response to MCMV has been reported to occur through 
the retinoic acid-inducible gene 1 (RIG-1) (Yoneyama et al 2004). Interestingly, although TLR7 
mediates recognition of ssRNA virus and TLR9 sense MCMV, Zucchini et al reported that TLR7 
and TLR9 redundantly affect IFN-production by pDC during MCMV infection in vivo. These 
authors observed a decrease in IFN-production in TLR7/9 double deficient mice that however 
was not detected in TLR9-/- mice (Zucchini et al 2008b). This is in agreement with our and Delale’s 
data, and further underlines the occurrence of TLR9-independent mechanisms. However, unlike 
TLR9-/- mice and TLR7/9 double-deficient mice, which were more susceptible to MCMV infection 
especially at high challenging doses (Delale et al 2005; Zucchini et al 2008b), we observed that 
pearl mice did not show an increased susceptibility to MCMV challenge when compared to wt 
controls. This difference may stem from the different players that had been knocked out in the 
various experimental mouse models (i.e., AP-3 versus TLR9). The AP-3 complex interacts with 
cleaved TLR9 and facilitates its trafficking to LAMP2 lysosome-related organelles (LRO), whereby 
TLR9 can engage TRAF3 and IRF7 and induce transcription of IFN genes. However, in AP-3 
deficient cells, TLR9 is unable to traffic to a specialized LAMP2
+
 LRO and to engage IRF7, but 
enters NF-kB endosome becoming competent to activate certain pro-inflammatory cytokine genes 
(Sasai et al 2010). Thus, it is conceivable that the ability of TLR9 to sense MCMV DNA and to 
stimulate the expression of inflammatory cytokines, even in AP-3-deficient mice, can account for 
the initiation of an antiviral response that leads to the control of MCMV infection. Furthermore, the 
observation of an efficient anti-MCMV response in AP-3-deficient mice is in agreement with data 




from Jessen et al, who reported that pearl mice infected with lymphocytic choriomeningitis virus 
(LCMV) control infection and clear the virus from all organs (Jessen et al 2013). 
In conclusion, our results with the AP-3-deficient mouse model, while confirming previous results 
obtained with different experimental models on the limited role of pDC in contributing to the 
overall response to MCMV infection, support the view that the impaired immune functions caused 
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Figure 1. BM-derived pDC from pearl mice are defective for IFN-α production in response to 
virus infections. CD34+ BM positive cells from pearl and C57B6/L wt mice were purified by 
positive immunoselection and treated to generate cDC or pDC as previously described (Del Prete 
and others 2004). pDC were infected at MOI of 1 with MCMV, HSV2, VSV or treated with CpG 
ODN 2216 (CpG-A) (20g/ml). (A, left panel) After 24 hours, total RNA was extracted, 
retrotranscribed with iScript cDNA Synthesis Kit (Bio-Rad Laboratories Inc.) and Real-time PCR 
performed with iQ
TM
 SYBR Green Supermix (Bio-Rad Laboratories Inc.) was carried out using 
primers specific for IFN- (sense, 5'-CCACAGGATCACTGTGTACCTGAGA -3'; antisense, 5'-
CTGATCACCTCCCAGGCACAG -3'). The cDNA were amplified for 45 cycles (95°C for 10 s 
and 60°C for 30 s). Results were normalized to the 18S signals and are presented as fold increase 
relative to the mRNA levels in unstimulated cells (assumed as the 1.0 value) (one representative 
experiment out of three). (A, center and right panels) IFN-α and TNF-α concentrations were 
measured by VeriKine Mouse IFN-α ELISA (PBL Interferon Source), and Duoset ELISA (R&D 
System) in the supernatants from BM-derived pDC stimulated as described above. (B) IFN-α and 
TNF-α concentrations were measured in the supernatants from BM-derived cDC infected with 
MCMV (MOI 1) or treated with LPS (1g/ml) for 24 hours. Data are expressed as means ± SEM 
(n=3). Results were analyzed by two-tailed Student t-test.
 *
p <0.05. 




Figure 2. Phenotypic characterization of DC subsets in pearl mice under steady-state 
conditions or following MCMV infection.  
Wt and pearl mice were left untreated or infected i.p. with 3x10
5
 PFU of MCMV, and spleens were 
harvested 36 hours later. (A) Splenocytes were analyzed by FACS CANTO II System (BD 
Biosciences) for the expression of CD11c, NK 1.1, CD11b, CD8α, B220 (all from BD Biosciences), 
Siglec-H (eBioscience). The FACS gating strategy used is shown.  Among the total DC (CD11c+), 
cDC were identified by the phenotypes CD11b+CD8- and CD11b-CD8+, and pDC by the 
phenotype B220+ Siglec-H+. 
(B) Frequencies for each population in the spleens of infected and uninfected mice are shown. Data 
are presented as means ± SEM (bars show averages of four mice per group and one of 2 
independent experiments is shown.) 
(C) Expression of cell-surface CD1d by CD11c+ cells from spleens of uninfected and MCMV-
infected wt and pearl mice. Histograms are representative plots of two independent experiments of 
four mice per group. Isotype control IgG is shown as grey filled histograms, untreated wt mice as 
black line and untreated pearl mice as red line, MCMV-infected wt and MCMV-infected pearl 
mice as blue line. Mean fluorescence intensity (MFI) of CD1d on CD11c+ cells from the spleen of 
uninfected or MCMV-infected wt and pearl mice is shown as means ± SEM (n=4) (C low left 




Figure 3. Cytokine production, survival and viral load in wt and pearl mice during MCMV 
infection. 
(A) Serum cytokines in wt and pearl mice during MCMV infection with 3x10
5
 PFU of a salivary 
gland stock virus i.p. injected. IFN-α (left upper panel) and TNF-α (lower left panel) serum levels 




were measured by ELISA at 36 hours. Values are expressed as means ± SEM of two independent 
experiments (four mice per group). Circulating IFN-α levels of infected mice were also determined 
at later time point (48 hours) (upper right panel) in two independent experiments (three mice per 
group). Wt and pearl mice were infected with MCMV or injected with α-GalCer (100 ng/ml) and 
analyzed for IFN-γ serum levels at 36 hours by ELISA (lower right panel). Data are combined from 
two independent experiments (four mice per group). (B) Survival curves of wt and pearl mice 







and monitored daily for a period of 15 days. The Kaplan-Meier survival analysis model was used to 
assess the survival of mice in each group. As indicated, the mortality was presented as the 
percentage of survival mice. (C) Virus production in wt and pearl mice infected with MCMV. The 







of MCMV. The viral loads were evaluated in the liver at 2 and 15 days p.i, and in salivary glands, 
lungs, and spleens at 15 days p.i. All organs were individually weighed, homogenized in DMEM-
10% FBS as a 10% (w/v) suspension and centrifuged at 12000 g x 15’ at 4 °C. Supernatants were 
titrated by plaque assay on NIH3T3 cells and given values were calculated for 100 mg of each 
organ. Results were analyzed by two-tailed Student t-test. *p <0.05. 
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